Showing results (1-10 of 375) with videos related to
Sort By:
Pageof 38
Journal of the American College of Cardiology|December 1, 1993
Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the Thrombolysis in Myocardial Infarction (TIMI) Phase II trialP B Berger, N A Ruocco, T J Ryan, et al.Journal of the American College of Cardiology|September 11, 1992
Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI IIP B Berger, N A Ruocco, T J Ryan, et al.International Journal of Cardiology|February 1, 1993
Effects of tissue plasminogen activator therapy on the frequency of acute right ventricular myocardial infarction associated with acute left ventricular infarctionJ M Kalan, S D Gertz, A H Kragel, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 15, 1995
New directions in research: report from the 10th International Conference on AIDSP B BergerCurrent Cardiology Reports|September 12, 2000
The thienopyridines in coronary artery diseaseP B BergerCMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 15, 1996
Hope and caution: report from the XI International Conference on AIDSP B BergerCatheterization and Cardiovascular Diagnosis|January 1, 1993
Use of excimer laser in the treatment of chronic total occlusion of a coronary artery that cannot be crossed with a balloon catheterP B Berger, J BresnahanCMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 15, 1996
The alluring myth of private medicineM Gordon, P B BergerThe American Journal of Cardiology|May 15, 1993
Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the thrombolysis in myocardial infarction [TIMI] II trial). The TIMI Research GroupP B Berger, N A Ruocco, T J Ryan, et al.Pageof 38